tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Royalty Pharma’s Strategic Moves and Growth Prospects Justify Buy Rating
PremiumRatingsRoyalty Pharma’s Strategic Moves and Growth Prospects Justify Buy Rating
26d ago
Zenas BioPharma, Royalty Pharma enter obexelimab funding agreement
Premium
The Fly
Zenas BioPharma, Royalty Pharma enter obexelimab funding agreement
27d ago
Royalty Pharma, Zenas BioPharma enter into obexelimab funding agreement
Premium
The Fly
Royalty Pharma, Zenas BioPharma enter into obexelimab funding agreement
27d ago
Henry Fernandez Steps Down from Royalty Pharma Board
PremiumCompany AnnouncementsHenry Fernandez Steps Down from Royalty Pharma Board
2M ago
Royalty Pharma’s Earnings Call Highlights Strong Growth and Strategic Moves
Premium
Company Announcements
Royalty Pharma’s Earnings Call Highlights Strong Growth and Strategic Moves
2M ago
Royalty Pharma Reports Strong Q2 2025 Results
Premium
Company Announcements
Royalty Pharma Reports Strong Q2 2025 Results
2M ago
Royalty Pharma price target raised to $54 from $51 at Morgan Stanley
PremiumThe FlyRoyalty Pharma price target raised to $54 from $51 at Morgan Stanley
3M ago
Strategic Financial Agreements and Promising Drug Developments Justify Buy Rating for Royalty Pharma
Premium
Ratings
Strategic Financial Agreements and Promising Drug Developments Justify Buy Rating for Royalty Pharma
3M ago
Royalty Pharma’s Strategic Partnership with Revolution Medicines: A High-Reward Investment Opportunity
Premium
Ratings
Royalty Pharma’s Strategic Partnership with Revolution Medicines: A High-Reward Investment Opportunity
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100